Results 141 to 150 of about 41,781 (278)

Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies

Pharmaceuticals
Purpose: Claudins are tight junction proteins partaking in epithelial-mesenchymal transition and cancer progression. In this study, we investigated the expression patterns of claudin-1 and claudin-4 in thyroid pathologies, discussed their links with the ...
Jędrzej Borowczak, Dariusz Łaszczych, Katarzyna Olejnik, Jakub Michalski, Anna Gutowska, Monika Kula, Anita Bator, Marta Sekielska-Domanowska, Roman Makarewicz, Andrzej Marszałek, Łukasz Szylberg, Magdalena Bodnar   +11 more
doaj   +1 more source

The Age Threshold of the 8th Edition AJCC Classification Is Useful for Indicating Patients with Aggressive Papillary Thyroid Cancer in Clinical Practice .

, 2020
Krzysztof Kaliszewski, Dorota Diakowska, Łukasz Nowak, Beata Wojtczak, Jerzy Rudnicki   +4 more
openalex   +1 more source

Multimodality MRI-Based Radiomics For Aggressiveness Prediction In Papillary Thyroid Cancer [PDF]

, 2021
Zedong Dai, Ran Wei, Hao Wang, Wenjuan Hu, Xilin Sun, Jie Zhu, Hong Li, Yaqiong Ge, Bin Song   +8 more
openalex   +1 more source

MicroRNA Profiling in Papillary Thyroid Cancer

International Journal of Molecular Sciences
Genetic alterations are well known to be related to the pathogenesis and prognosis of papillary thyroid carcinoma (PTC). Some miRNA expression dysregulations have previously been described in the context of cancer development including thyroid carcinoma.
Richard Armos, Bence Bojtor, Marton Papp, Ildiko Illyes, Balazs Lengyel, Andras Kiss, Balazs Szili, Balint Tobias, Bernadett Balla, Henriett Piko, Anett Illes, Zsuzsanna Putz, Andras Kiss, Erika Toth, Istvan Takacs, Janos P. Kosa, Peter Lakatos   +16 more
openaire   +2 more sources

Partial Laryngectomy for Thyroid Cancer: A Single Institution Case Series With Operative Techniques

Head &Neck, Volume 48, Issue 2, Page E20-E24, February 2026.
ABSTRACT Background Partial laryngectomy has been well described as a management option for T1–3 laryngeal squamous cell cancers. However, there are a few case reports of partial laryngeal surgery for locally advanced thyroid carcinoma. Methods This is a case series of five patients with thyroid carcinoma (one primary and four recurrent) with laryngeal
Ella E. Hawes, Victoria E. Banuchi, Anastasios Maniakas, Jennifer R. Wang, Paul H. Graham, Julia D. Diersing, Naifa L. Busaidy, Maria E. Cabanillas, Ramona Dadu, Sarah Hamidi, Priyanka Iyer, Steven G. Waguespack, Salmaan Ahmed, Sahar Alizada, Alexandra Belcastro, Ranim Alsharif, Mimi I. Hu, Mark E. Zafereo   +17 more
wiley   +1 more source

Is the incidence of early‐onset cancers increasing in the northeast of Italy? A 30‐year analysis of the regional cancer registration data by age, 1987–2019

International Journal of Cancer, Volume 158, Issue 3, Page 532-545, 1 February 2026.
Whats New? This observational study of the incidence trends of malignancy by site, stratified by age group and sex, over three decades in a large northern Italian population reveals a heterogeneous landscape among younger adults (aged under 50). Invasive cutaneous melanoma in both sexes, testicular cancer and multiple myeloma in males, and breast ...
Alessandra Buja, Chiara Trevisiol, Andrea Miatton, Stefano Guzzinati, Emanuela Bovo, Simone Mocellin, Alberto Fantin, Massimo Rugge, Vincenzo Bronte, Manuel Zorzi   +9 more
wiley   +1 more source

Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland [PDF]

, 2018
Objective: Several studies have reported upward incidence trends of papillary thyroid cancer. It is unclear whether these trends reflect a real risk increase, by some attributed to iodine supplementation, or an artificial one, due to increased diagnostic
Bouchardy, Christine, Fioretta, Gerald, Franceschi, Silvia, Pache, Jean-Claude, Raymond, Luc, Schubert, Hyma, Verkooijen, Helena   +6 more
core  

Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors [PDF]

, 2022
Peitao Zhang, Haixia Guan, Shukai Yuan, Huili Cheng, Jian Zheng, Zhenlei Zhang, Yifan Liu, Yang Yu, Zhaowei Meng, Xiangqian Zheng, Li Zhao   +10 more
openalex   +1 more source

Loss of METTL3 m6A methyltransferase results in short‐term progression and poor treatment outcome of bladder cancer patients

International Journal of Cancer, Volume 158, Issue 3, Page 763-774, 1 February 2026.
What's new? Bladder cancer exhibits a highly heterogeneous molecular landscape and treatment response. The dysregulation of RNA modifications such as m6A has been involved in cancer initiation and progression. This study comprehensively analyzed the expression of the main catalytic component of the m6A methylation machinery in bladder tumors across one
Katerina‐Marina Pilala, Stella Koroneou, Maria‐Alexandra Papadimitriou, Konstantina Panoutsopoulou, Konstantinos Soureas, Georgios‐Christos Giagkos, Panagiotis Levis, Dimitrios Linardoutsos, Konstantinos Stravodimos, Margaritis Avgeris, Andreas Scorilas   +10 more
wiley   +1 more source

Unmasking Hidden Mediastinal Involvement in Papillary Thyroid Carcinoma: A Case Report on the Diagnostic Utilization of EBUS-TBNA

Case Reports in Pulmonology
The global incidence of thyroid cancer is on the rise, with papillary thyroid carcinoma (PTC) accounting for approximately 80% of all cases. The incidence of mediastinal lymph node metastases in papillary thyroid cancer ranges from 0.7% to 27%. This case
Albatol N. Rashed, Khalid S. Alokla, Ali F. Alfayez, Luai Sallout   +3 more
doaj   +1 more source